Trial Profile
Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke (CLEAR Stroke) Trial
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 07 Apr 2016
Price :
$35
*
At a glance
- Drugs Alteplase (Primary) ; Eptifibatide (Primary)
- Indications Embolism and thrombosis; Stroke
- Focus Adverse reactions; Therapeutic Use
- Acronyms CLEAR
- 19 Feb 2016 Results of pooled analysis (n=247) of this and other 2 trials (CLEAR-ER and CLEAR-FDR) presented at the 41st International Stroke Conference
- 01 Dec 2008 Primary endpoint results published in Stroke 39: 3268-3276, No. 12, Dec 2008
- 06 Dec 2007 Status changed from in progress to completed.